Neogen Stock Gets Reduced EPS Estimate from Zacks Research

Neogen Corporation (NASDAQ:NEOG) – Research analysts at Zacks Research lowered their Q2 2027 earnings per share estimates for Neogen in a note issued to investors on Tuesday, October 27th. Zacks Research analyst Team now forecasts that the company will post earnings of $0.06 per share for the quarter, down from their previous estimate of $0.08. The consensus estimate for Neogen’s current full-year earnings is $0.28 per share. Zacks Research also issued estimates for Neogen’s Q1 2028 earnings at $0.07 EPS.

Several other research firms have also recently weighed in on NEOG. Weiss Ratings raised shares of Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th. Piper Sandler upgraded Neogen from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $13.00 to $14.00 in a research report on Wednesday, August 26th. Guggenheim restated a “buy” rating and issued a $14.00 target price (up from $12.00) on shares of Neogen in a research note on Wednesday, September 30th. Finally, Wall Street Zen cut Neogen from a “strong-buy” rating to a “buy” rating in a report on Sunday, October 11th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $12.67.

Neogen Stock Performance

Neogen stock opened at $12.26 on Friday. Neogen has a 1-year low of $5.37 and a 1-year high of $14.26. The company has a current ratio of 3.90, a quick ratio of 2.92 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $2.68 billion, a PE ratio of -49.04, a price-to-earnings-growth ratio of 4.33 and a beta of 1.79. The firm’s 50 day simple moving average is $12.23 and its 200 day simple moving average is $10.41.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings results on Tuesday, October 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.03. Neogen had a positive return on equity of 3.29% and a negative net margin of 6.35%. The firm had revenue of $222.80 million for the quarter, compared to analysts’ expectations of $208.18 million. During the same period in the prior year, the business posted $0.04 earnings per share. The company’s revenue was up 6.5% on a year-over-year basis.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NEOG. Canton Hathaway LLC purchased a new position in shares of Neogen in the 3rd quarter worth about $26,000. Nykredit A S purchased a new stake in Neogen during the 2nd quarter valued at about $28,000. Farther Finance Advisors LLC grew its position in Neogen by 76.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,184 shares of the company’s stock valued at $28,000 after purchasing an additional 944 shares during the last quarter. Public Employees Retirement System of Ohio bought a new stake in Neogen during the 2nd quarter valued at about $34,000. Finally, Integrated Wealth Concepts LLC bought a new stake in Neogen during the 2nd quarter valued at about $73,000. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

Neogen Company Profile

Neogen Corporation develops and markets products and services designed to help protect the food supply and support animal health. Its food safety offerings include diagnostic tests and laboratory products used to detect pathogens, allergens, mycotoxins, genetically modified organisms, veterinary drug residues, and other contaminants in food and agricultural environments.

The company also provides sanitation and hygiene products, environmental monitoring solutions, and software and data-management tools that help food processors, retailers, laboratories, and other organizations manage food safety programs.